JP6585030B2 - 自閉症スペクトラム障害におけるｇａｂａ−ｂアゴニスト薬物活性の脳磁図バイオマーカー - Google Patents

自閉症スペクトラム障害におけるｇａｂａ−ｂアゴニスト薬物活性の脳磁図バイオマーカー Download PDF

Info

Publication number
JP6585030B2
JP6585030B2 JP2016503336A JP2016503336A JP6585030B2 JP 6585030 B2 JP6585030 B2 JP 6585030B2 JP 2016503336 A JP2016503336 A JP 2016503336A JP 2016503336 A JP2016503336 A JP 2016503336A JP 6585030 B2 JP6585030 B2 JP 6585030B2
Authority
JP
Japan
Prior art keywords
asd
age
activity
latency
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016503336A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519595A5 (enExample
JP2016519595A (ja
Inventor
ティモシー・ピー・エル・ロバーツ
ジェイムズ・クリストファー・エドガー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Original Assignee
Childrens Hospital of Philadelphia CHOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Philadelphia CHOP filed Critical Childrens Hospital of Philadelphia CHOP
Publication of JP2016519595A publication Critical patent/JP2016519595A/ja
Publication of JP2016519595A5 publication Critical patent/JP2016519595A5/ja
Application granted granted Critical
Publication of JP6585030B2 publication Critical patent/JP6585030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/242—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents
    • A61B5/245—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals
    • A61B5/246—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals using evoked responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016503336A 2013-03-15 2014-03-17 自閉症スペクトラム障害におけるｇａｂａ−ｂアゴニスト薬物活性の脳磁図バイオマーカー Active JP6585030B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361787077P 2013-03-15 2013-03-15
US61/787,077 2013-03-15
PCT/US2014/030138 WO2014145382A2 (en) 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders

Publications (3)

Publication Number Publication Date
JP2016519595A JP2016519595A (ja) 2016-07-07
JP2016519595A5 JP2016519595A5 (enExample) 2017-04-27
JP6585030B2 true JP6585030B2 (ja) 2019-10-02

Family

ID=51538466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016503336A Active JP6585030B2 (ja) 2013-03-15 2014-03-17 自閉症スペクトラム障害におけるｇａｂａ−ｂアゴニスト薬物活性の脳磁図バイオマーカー

Country Status (6)

Country Link
US (1) US10342480B2 (enExample)
EP (1) EP2967405A4 (enExample)
JP (1) JP6585030B2 (enExample)
AU (1) AU2014233048B2 (enExample)
CA (1) CA2907494C (enExample)
WO (1) WO2014145382A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018194959A1 (en) * 2017-04-17 2018-10-25 Miron Oren Auditory brainstem response for autism prediction
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11426073B2 (en) * 2018-04-27 2022-08-30 Washington University Imaging nerve function and pathologies using diffusion basis spectrum imaging
WO2020056418A1 (en) 2018-09-14 2020-03-19 Neuroenhancement Lab, LLC System and method of improving sleep
FI20185893A1 (fi) * 2018-10-23 2020-04-24 Elekta Oy Päähän asennettava laitteisto
US11103171B2 (en) * 2018-10-23 2021-08-31 BlackThor Therapeutics, Ine. Systems and methods for screening, diagnosing, and stratifying patients
WO2020186148A1 (en) 2019-03-13 2020-09-17 The Children's Hospital Of Philadelphia Methods for the detection of brain injury
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
WO2021096946A1 (en) * 2019-11-15 2021-05-20 The University Of Chicago Cancer detection based on four quadrant mapping and matrix analysis of image data
US20230210425A1 (en) * 2022-01-05 2023-07-06 Tdk Corporation Methods and Devices for Electromagnetic Measurements from Ear Cavity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2540295A1 (en) * 2011-06-27 2013-01-02 Centre national de la recherche scientifique Compositions for the treatment of Fragile X syndrome

Also Published As

Publication number Publication date
US20160022207A1 (en) 2016-01-28
AU2014233048A1 (en) 2015-10-08
CA2907494A1 (en) 2014-09-18
WO2014145382A2 (en) 2014-09-18
WO2014145382A8 (en) 2014-12-31
EP2967405A2 (en) 2016-01-20
US10342480B2 (en) 2019-07-09
WO2014145382A3 (en) 2014-10-30
EP2967405A4 (en) 2017-01-11
CA2907494C (en) 2022-10-04
AU2014233048B2 (en) 2019-01-03
JP2016519595A (ja) 2016-07-07

Similar Documents

Publication Publication Date Title
JP6585030B2 (ja) 自閉症スペクトラム障害におけるｇａｂａ−ｂアゴニスト薬物活性の脳磁図バイオマーカー
Nugent et al. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Casula et al. Decreased frontal gamma activity in Alzheimer disease patients
Edgar et al. Neuromagnetic oscillations predict evoked-response latency delays and core language deficits in autism spectrum disorders
Horváth et al. EEG and ERP biomarkers of Alzheimer's disease: a critical review
Nir et al. Interhemispheric correlations of slow spontaneous neuronal fluctuations revealed in human sensory cortex
Minshew et al. Neurologic aspects of autism
Krieg et al. Functional language shift to the right hemisphere in patients with language-eloquent brain tumors
Deslandes et al. Electroencephalographic frontal asymmetry and depressive symptoms in the elderly
O'Donnell et al. The auditory steady-state response (ASSR): a translational biomarker for schizophrenia
Tecchio et al. Auditory sensory processing in autism: a magnetoencephalographic study
Niu et al. Reduced frontal activation during a working memory task in mild cognitive impairment: a non‐invasive near‐infrared spectroscopy study
Huneau et al. Altered dynamics of neurovascular coupling in CADASIL
Zhang et al. Near‐infrared spectroscopy for examination of prefrontal activation during cognitive tasks in patients with major depressive disorder: A meta‐analysis of observational studies
Grieder et al. Discovering EEG resting state alterations of semantic dementia
Dickinson et al. Early patterns of functional brain development associated with autism spectrum disorder in tuberous sclerosis complex
Thönnessen et al. Optimized mismatch negativity paradigm reflects deficits in schizophrenia patients: A combined EEG and MEG study
Zambito-Marsala et al. Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials
Wu et al. Resting-state electroencephalography of neural oscillation and functional connectivity patterns in late-life depression
Raggi et al. A review on P300 in obsessive-compulsive disorder
Hogan et al. Brain response to unexpected novel noises in children with low and high trait anxiety
Kegyes-Brassai et al. Disruption of sleep macro-and microstructure in Alzheimer’s disease: overlaps between neuropsychology, neurophysiology, and neuroimaging
Werner et al. Temporal lobe impairment in W est syndrome: Event‐related potential evidence
Critzer et al. Water and brain function: effects of hydration status on neurostimulation with transcranial magnetic stimulation
Vicente et al. Subjective emotional experience at different stages of Parkinson's disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170316

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181102

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190419

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190619

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190717

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190806

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190904

R150 Certificate of patent or registration of utility model

Ref document number: 6585030

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250